Tingxun Lu

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma”.

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma

Experimental Hematology and Oncology(2023)10.1186/s40164-023-00432-z

N/A

0DataRank · unranked

30 citations

Jie Zhang, Zijun Y. Xu‐Monette, Ken H. Young, Tingxun Lu

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1554

N/A

0DataRank · unranked

19 citations

Yong Li, Thomas M. Snyder, Tiantian Yu, Tingxun Lu, Alexandar Tzankov +26 more

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma

International Journal of Molecular Sciences(2023)10.3390/ijms24065493

N/A

0DataRank · unranked

21 citations

Tingxun Lu, Zijun Y. Xu‐Monette, Ken H. Young, Yuyang Pang